Articles on PBS

Displaying 1 - 20 of 56 articles

H.F. ‘Gerry’ Lenfest, left, donated tens of millions of dollars to sustain Philadelphia’s newspapers. AP Photo/Rich Schultz

The pace of nonprofit media growth is picking up

Without credible news and information, a healthy democracy is not possible.
When looking for the right pill, women want to weigh up the cost, safety, efficacy and side effects of the pill. NordWood Themes

How to choose the right contraceptive pill for you

There are more than 30 different types of contraceptive pills. But brand names such as Microgynon, Levlen, Yaz and Brenda give little indication of the ingredients, dose or who should use them.
More knowledge about your genetic makeup enables you to make better-informed choices – but at what cost? Shutterstock

Not all genetic tests should be publicly funded – here’s why

It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
Applications to list drugs on the PBS are usually submitted by the manufacturers of those drugs. from shutterstock.com

We don’t need to change how we subsidise ‘breakthrough’ cancer treatments

Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer. from shutterstock.com

New drugs on the PBS: what they do and why we need them

An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix that. from www.shutterstock.com

How to slash half a billion dollars a year from Australia’s drugs bill

Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
Donald Trump answers a question from CNN moderator Wolf Blitzer. Mike Blake/Reuters

Why presidential debates need real-time fact-checking

With the presidential debates being derided as evidence we live in a “post-fact" political world, why aren't the moderators “truth vigilantes”?
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
The PBAC must make tough decisions about which cancer drugs to subsidise. Eric Gaillard/Reuters

New cancer drugs are very expensive - here’s how we work out value for our money

Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can't afford all of them. How then are decisions about which drugs to subsidise made?

Top contributors

More